Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis?

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 9, 2004, Pages 885-890

  Burra, P ^a,b   Senzolo, M ^a   Pizzolato, G ^a   Ermani, M ^a   Chierichetti, F ^a   Bassanello, M ^a   Naccarato, R ^a   Dam, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Dept Surg Gastroenterological Sci ^*  (Italy)

Author keywords

Cerebral blood flow; Hepatic encephalopathy; Liver cirrhosis; Liver disease aetiology; Single positron emission tomography

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ALCOHOL ABUSE; ARTICLE; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RANK SUM TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; CHOLANGITIS, SCLEROSING; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 4444290642     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200409000-00012     Document Type: Article

References (38)

1. Dam M, Burra P, Tedeschi U, Cagnin A, Chierichetti F, Ermani M, et al. Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single photon emission computed tomography: effect of liver transplantation. J Hepatol 1998; 28:78-84.
2. Iwasa M, Matsumura K, Kaito M, Ikoma J, Kobayashi Y, Nakagawa N, et al. Decrease of regional cerebral blood flow in liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12:1001-1006.
3. Lockwood AH, Yap EW, Rhoades HM, Wong WH. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 1991; 11:331-336.
4. O'Carroll RE, Hayes PC, Ebmeier KP. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 1991; 1:1250-1253.
5. Yazgan Y, Narin Y, Demirturk L, Saracoglu M, Ercan M, Akyatan N, et al. Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. J Gastroenterol Hepatol 2003; 18:1162-1167.
6. Trzepacz PT, Tarter RE, Shah A, Tringali R, Faett DG, Van Thiel DH. SPECT scan and cognitive findings in subclinical hepatic encephalopathy. J Neuropsychiatry Clin Neurosci 1994; 6:492.
7. Nicolas JM, Catafau AM, Estruch R, Lomena FJ, Salamero M, Herranz R, et al. Regional cerebral blood flow-SPECT in chronic alcoholism: relation to neuropsychological testing. J Nucl Med 1993; 34:1452-1459.
8. Valmier J, Tonchon J, Zanca M, Fauchere V, Bories P, Baldy-Moulinier M. Correlations between cerebral grey matter flow and hepatic histology in alcoholism. Eur Neurol 1986; 35:197-201.
9. Shimojo S, Scheinberg P, Reinmuth D. Cerebral blood flow and metabolism in the Wernicke-Korsakoff Syndrome. J Clin Invest 1967; 46:849-854.
10. Roger RL, Meyer JS, Shaw TG, Mortel KF. Reduction in regional cerebral blood flow associated with chronic consumption of alcohol. J Am Geriatr Soc 1983; 31:540-543.
11. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37:349-354.
12. Maggi F, Giorgi M, Fornai C, Morrica A, Vatteroni ML, Pistello M, et al. Detection of quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999; 5:319-323.
13. Lee DH, Jamal H, Regestein FG, Perillo RP. Morbidity of chronic hepatitis C seen in tertiary care medical center. Dig Dis Sci 1997; 42:186-191.
14. Hunt CM, Dominitz JA, Bute BP, Waters B, Williams DM. Effect of interferon-alpha treatment of chronic hepatitis C on health related quality of life. Dig Dis Sci 1997; 42:2482-2486.
15. Foster GR, Godlin RD, Thomas HC. Chronic hepatits C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27:209-212.
16. Wahler JB, Swain MG, Carson R, Bergasa NV, Jones EA. Blood-brain barrier permeability is markedly decreased in cholestasis in the rat. Hepatology 1993; 17:1103-1108.
17. Thorton JR, Losowsky MS. Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis. Br Med J 1988; 297:1241-1242.
18. Laidlaw J, Read AE, Sherlock S. Morphine tolerance in hepatic cirrhosis. Gastroenterology 1961; 40:389-396.
19. Chu NS, Yang SS, Liaw YF. Evoked potentials in liver diseases. J Gastroenterol Hepatol 1997; 12:S288-293.
20. Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S. Positron emission tomography localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 1993; 18:1061-1068.
21. Iwasa M, Kaito M, Adachi Y, Watanabe Y, Matsumura K, Takeda K. Cerebral blood flow in basal ganglia is correlated with clinical signs of hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 2002; 97:763-764.
22. Catafau AM, Kulisevsky J, Berna L, Pujol J, Martin JC, Otermin P, et al. Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychological impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 2000; 41:405-410.
23. Thompson-Schill SL, Jonides J, Marshuetz C, Smith EE, D'Esposito M, Kann IP, et al. Effect of frontal lobe damage on interference effects in working memory. Cogn Affect Behav Neurosci 2002; 2:109-120.
24. Dupont S. Investigating temporal pole function by functional imaging. Epileptic Disord 2002; 4:S17-S22.
25. Gansler DA, Harris GJ, Oscar-Berman M, Streeter C, Lewis RF, Ahmed I, Achong D. Hypoperfusion of inferior frontal brain regions in abstinent alcoholics: a pilot SPECT study. J Stud Alcohol 2000; 61:32-37.
26. Cala LA, Jones B, Mastaglia FL, Wiley B. Brain atrophy and withdrawal impairment in heavy drinkers: a clinical, psychometric and tomography study. Aust N Z J Med 1978; 8:147-153.
27. Ron MA. Brain damage in chronic alcoholism: a neuropathological, neuroradiological and psychological review. Psychol Med 1977; 7: 103-112.
28. Amodio P, Pellegrini A, Amista P, Luise S, Del Piccolo F, Mapelli D, et al. Neuropsychological-neurophysiological alterations and brain atrophy in cirrhotic patients. Metab Brain Dis 2003; 18:63-78.
29. Bernthal P, Hays A, Tarter RE, Van Thiel D, Lecky J, Hegedus A. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychological test performance. Hepatology 1987; 7:107-114.
30. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, et al. The dynamics of ammonia metabolism in man. Effect of liver disease and hyperammonemia. J Clin Invest 1979; 63:449-460.
31. Forton DM, Alisop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38-39.
32. Forton DM, Thomas HC, Murphy CA, Alisop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-439.
33. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999; 11:833-888.
34. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired- immunodeficiency syndrome: specific detection of negative strand RNA in various tissue. Hepatology 1998; 28:1398-1401.
35. Floreani A, Marchiori M, Bonato S, Zucchetto M, Naccarato R, Chiaramonte M. Cognitive assessment in primary biliary cirrhosis: a case-control study. Am J Gastroenterol 1995; 90:250-253.
36. Navasa M, Pares A, Brughera M, Caballeria J, Bosch J, Rodes J. Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 1987; 5:292-298.
37. Exton MS, Baase J, Pithan V, Goebel MU, Limmorth V, Schedlowski M. Neuropsychological performance and mood states after acute interferon-beta-1b administration in healthy males. Neuropsychobiology 2002; 45:199-204.
38. Dieperink E, Ho SB, Thuras P, Willenbring ML. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003; 44:104-112.